Barton Shane bought BIOA
June 30, 2026 · Form 4 insider transaction
Barton Shane bought 7,861 shares of BioAge Labs, Inc. at $4.38 per share, a transaction worth $34.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
7,861
Price
$4.38
Total value
$34.4K
InsiderBarton Shane
RoleOfficer
CompanyBioAge Labs, Inc. (BIOA)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 30, 2026
Filing dateJuly 1, 2026
Shares owned after20,216
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025.